Loading
SARASOTA — Omeza LLC maxed out its current funding round limit at $7 million in July, having already raised $5.75 million as of its April 1 target.
The additional funds closed just prior to the company’s second board meeting at the company’s headquarters in Sarasota, according to a press release.
Company founder and CEO Tom Gardner says in a statement the level of interest exceeded the agreed-upon investment limits of this round as set by the board. Total investment in Omeza through the first two rounds is now $8 million.
Omeza is a medical technology and consumer health care products company initially focused on closing chronic wounds and preventing their recurrence.
Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.
